NM_003560.4:c.2246G>C
Variant summary
Our verdict is Likely pathogenic. Variant got 9 ACMG points: 9P and 0B. PM1PM2PP3_StrongPP5
The NM_003560.4(PLA2G6):āc.2246G>Cā(p.Trp749Ser) variant causes a missense change. The variant allele was found at a frequency of 0.0000128 in 1,402,780 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_003560.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 9 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.0000128 AC: 18AN: 1402780Hom.: 0 Cov.: 31 AF XY: 0.0000101 AC XY: 7AN XY: 692856
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:1
The W749S variant in the PLA2G6 gene has not been published as a pathogenic variant, nor has it been reported as a benign polymorphism to our knowledge. The W749S variant was not observed in approximately 6,350 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The W749S variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species. In silico analysis predicts this variant is probably damaging to the protein structure/function. Furthermore, numerous missense variants in nearby residues (R741Q; R741W; R745W; R745P; R747W; E751K; G754V) have been reported in the Human Gene Mutation Database in association with PLA2G6-related disorders (Stenson et al., 2014), supporting the functional importance of this region of the protein. The W749S variant is a strong candidate for a disease-causing variant however, the possibility it may be a rare benign variant cannot be excluded -
Iron accumulation in brain Pathogenic:1
- -
not specified Uncertain:1
Variant summary: PLA2G6 c.2246G>C (p.Trp749Ser) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 157752 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.2246G>C in individuals affected with Neurodegeneration With Brain Iron Accumulation and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 159763). Based on the evidence outlined above, the variant was classified as uncertain significance. -
Infantile neuroaxonal dystrophy Uncertain:1
This sequence change replaces tryptophan, which is neutral and slightly polar, with serine, which is neutral and polar, at codon 749 of the PLA2G6 protein (p.Trp749Ser). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with PLA2G6-related conditions. ClinVar contains an entry for this variant (Variation ID: 159763). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PLA2G6 protein function with a positive predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
PLA2G6-associated neurodegeneration Uncertain:1
The p.Trp749Ser variant in PLA2G6 has not been previously reported in the literature in individuals with PLA2G6-associated neurodegeneration, but has been identified in 0.001% (17/1150436) of European (non-Finnish) chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP ID: rs587784351). Although this variant has been seen in the general population in a heterozygous state, its frequency is low enough to be consistent with a recessive carrier frequency. This variant has also been reported in ClinVar (VCV000159763.14) and has been interpreted as likely pathogenic by Genetic Services Laboratory (University of Chicago) and GeneDx, and a variant of uncertain significance by Labcorp Genetics. Computational prediction tools and conservation analyses suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. In summary, the clinical significance of the p.Trp749Ser variant is uncertain. ACMG/AMP Criteria applied: PM2_supporting, PP3_moderate (Richards 2015). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at